Related Experiment Videos
Thalidomide in POEMS syndrome: case report
Marjatta Sinisalo1, Aki Hietaharju, Jukka Sauranen
1Department of Internal Medicine, Tampere University Hospital, Tampere, Finland. marjatta.sinisalo@pshp.fi
American Journal of Hematology
|April 29, 2004
Summary
POEMS syndrome, a rare disorder, can cause severe symptoms like organomegaly and pulmonary hypertension. Thalidomide treatment led to significant clinical improvement in a patient with this incapacitating condition.
Area of Science:
- Hematology
- Nephrology
- Neurology
Background:
- POEMS syndrome is a rare multisystem disorder.
- Characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS).
- Can involve glomerulonephritis, ascites, and pulmonary hypertension.
Observation:
- A patient presented with incapacitating POEMS syndrome.
- Symptoms included massive ascites and pulmonary hypertension.
- The patient also had mesangiocapillary glomerulonephritis.
Findings:
- Thalidomide administration resulted in dramatic clinical improvement.
- Thalidomide exhibits anti-angiogenetic, anti-proliferative, and anti-cytokine properties.
- These properties may explain the therapeutic effect in POEMS syndrome.
Implications:
- Thalidomide is a potential therapeutic option for severe POEMS syndrome.
- Understanding thalidomide's mechanisms may guide future treatment strategies.
- Further research is warranted to confirm efficacy and safety.